Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitral valve prolapse.

T O Cheng1

  • 1George Washington University School of Medicine and Health Sciences, Washington, D.C.

Disease-A-Month : DM
|September 1, 1987
PubMed
Summary
This summary is machine-generated.

Mitral valve prolapse (MVP) is a common heart condition. While often benign, it can lead to serious complications, requiring medical intervention in some cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk-to-benefit ratio of Swan-Ganz catheterization.

AJR. American journal of roentgenology·1997
Same author

Ventricular aneurysm and coronary artery disease: the hen and the egg?

Catheterization and cardiovascular diagnosis·1997
Same author

Mitral valve prolapse secondary to rheumatic valvulitis.

International journal of cardiology·1997
Same author

Underuse of warfarin in atrial fibrillation.

Archives of internal medicine·1997
Same author

What is ESMIR?

The American journal of cardiology·1997
Same author

Hypertrophic obstructive cardiomyopathy: alternative therapeutic options.

Clinical cardiology·1997
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Cardiology
  • Valvular Heart Disease

Background:

  • Mitral valve prolapse (MVP) is a prevalent valvular heart disorder, characterized clinically by the click-murmur syndrome and pathologically by the floppy valve syndrome.
  • It is a common congenital heart disease and the most frequently diagnosed valve disorder in the United States and globally.
  • MVP can be associated with various other medical conditions.

Purpose of the Study:

  • To provide a comprehensive overview of mitral valve prolapse, including its clinical presentation, diagnosis, associated conditions, and management strategies.
  • To highlight the spectrum of outcomes, from asymptomatic cases to severe complications.

Main Methods:

  • Clinical diagnosis based on characteristic signs like midsystolic click and late systolic murmur.
  • Echocardiography as a supportive diagnostic tool when necessary.

Related Experiment Videos

  • Review of existing literature and clinical data on mitral valve prolapse.

    • Main Results:

    • The majority of patients with MVP experience no significant long-term issues.
    • Potential major complications include chest pain, mitral regurgitation, infective endocarditis, thromboembolism, arrhythmias, and sudden death.
    • Most patients, especially those without objective findings or severe symptoms, require only reassurance.

    Conclusions:

    • Mitral valve prolapse is a common condition with a generally favorable prognosis.
    • While often asymptomatic, awareness of potential severe complications is crucial for timely intervention.
    • Treatment is typically conservative, focusing on reassurance, but may involve beta-blockers, antiplatelet agents, or surgery for specific complications.